No Data
Lakeland Industries' (NASDAQ:LAKE) Investors Will Be Pleased With Their Stellar 140% Return Over the Last Five Years
The only manufacturer of smallpox vaccine has submitted clinical data and plans to expand the scope of vaccination.
Bavarian Nordic announced that it has submitted clinical data to the European Medicines Agency to seek an expansion of the indication for its Imvanex vaccine to adolescents aged 12-17. Yesterday, Sweden, the neighboring country of Denmark, reported the first confirmed case of monkeypox, which is also the first case confirmed outside the African continent since this epidemic outbreak.
With 68% Ownership of the Shares, Lakeland Industries, Inc. (NASDAQ:LAKE) Is Heavily Dominated by Institutional Owners
Lakeland Industries To Go Ex-Dividend On August 15th, 2024 With 0.03 USD Dividend Per Share
Lakeland Declares $0.03 Dividend
What Makes Lakeland Industries (LAKE) an Exciting Investment Opportunity?
No Data
